|
Originally published In Press as doi:10.1074/jbc.M704748200 on October 8, 2007
J. Biol. Chem., Vol. 283, Issue 1, 237-243, January 4, 2008
Pyruvate Dehydrogenase Complex Deficiency Caused by Ubiquitination and Proteasome-mediated Degradation of the E1β Subunit*
Zongchao Han ,
Li Zhong ,
Arun Srivastava ¶, and
Peter W. Stacpoole¶||**1
From the
Departments of Pediatrics, Division of Cellular and Molecular Therapy, Molecular Genetics and Microbiology, ¶The General Clinical Research Center, ||Medicine, Division of Endocrinology and Metabolism, and **Biochemistry and Molecular Biology, University of Florida College of Medicine, Gainesville, Florida 32610
Congenital deficiencies of the human pyruvate dehydrogenase (PDH) complex are considered to be due to loss of function mutations in one of the component enzymes. Here we describe a case of PDH deficiency associated with the PDH E1β subunit (PDHB) gene. The clinical phenotype of the patient was consistent with reported cases of PDH deficiency. Cultured skin fibroblasts demonstrated a 55% reduction in PDH activity and markedly decreased immunoreactivity for PDHB protein, compared with healthy controls. Surprisingly, nucleotide sequence analyses of cDNAs corresponding to the patient PDH E1 (PDHA1) and PDHB genes revealed no pathological mutations. Moreover, the relative expression level of PDHB mRNA and the rates of transcription and translation of the PDHB gene were normal. However, PDC activity could be restored in cells from this patient following treatment with MG132, a specific proteasome inhibitor, and normal levels of E1β could be detected in MG132-treated cells. Similar results were obtained following treatment with Tyr-phostin 23 (Tyr23), a specific inhibitor of epidermal growth factor receptor-protein-tyrosine kinase (EGFR-PTK), which also restored E1β protein levels to those in cells from healthy subjects or from patients with PDHA1 deficiency. The index patient's cells contained a high basal level of EGFR-PTK activity that correlated with the high level of ubiquitination of cellular proteins, although the total EGFR protein levels were similar to those in cells from El -deficient subjects and healthy subjects. These data indicate that PDH deficiency in our patient involves a post-translational modification in which EGFR-PTK-mediated tyrosine phosphorylation of the E1β protein leads to enhanced ubiquitination followed by proteasome-mediated degradation. They also provide a novel mechanism accounting for congenital deficiency of the PDH complex and perhaps other inborn errors of metabolism.
Received for publication, June 8, 2007
, and in revised form, September 10, 2007.
* This work was supported in part by the Zachary Foundation and by National Institutes of Health Grants M01-000082 and P01 DK-058327. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 To whom correspondence should be addressed: Dept. of Medicine (Division of Endocrinology and Metabolism), 1600 SW Archer Rd., Gainesville, FL 32610. Tel.: 352-392-2321; Fax: 352-846-0990; E-mail: peter.stacpoole{at}medicine.ufl.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Chen, B. P. Mooney, M. Hajduch, T. Joshi, M. Zhou, D. Xu, and J. J. Thelen
System Analysis of an Arabidopsis Mutant Altered in de Novo Fatty Acid Synthesis Reveals Diverse Changes in Seed Composition and Metabolism
Plant Physiology,
May 1, 2009;
150(1):
27 - 41.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|